Precision BioSciences to Present at the Needham Virtual Healthcare Conference Durham, North Carolina-based Precision BioSciences, Inc. (DTIL) is set to showcase its innovative gene editing technologies at the 24th Annual Needham Virtual Healthcare Conference. Scheduled for Monday, April 7, 2025, Precision BioSciences management will present in Track 2 at 3:00 PM ET. About Precision BioSciences…
CalciMedica’s New Appointment: A Potential Game-Changer in Inflammatory and Immunologic Diseases CalciMedica Inc., a pioneering biopharmaceutical company specializing in the development of novel calcium release-activated calcium (CRAC) channel inhibition therapies, recently announced the appointment of a new scientific leader. Dr. Rachel Leheny, a renowned pharmacologist and immunologist, will be joining the Company as its Vice…
Bronstein, Gewirtz & Grossman, LLC Files Class Action Lawsuit Against SoundHound AI, Inc. On April 1, 2025, Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, announced the filing of a class action lawsuit against SoundHound AI, Inc. (“SoundHound” or “the Company”) (NASDAQ:SOUN) and certain of its officers. The complaint alleges that SoundHound and its…
Apellis Pharmaceuticals’ EMPAVELI® Receives Priority Review from FDA for Severe and Rare Kidney Diseases Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, recently announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review designation for the supplemental New Drug Application (sNDA) of EMPAVELI® (pegcetacoplan) for the treatment of C3 glomerulopathy (C3G)…
Predictive Oncology’s Q4 2024 Financial Report and Corporate Update Pittsburgh, PA – April 1, 2025 – Predictive Oncology, Inc. (Nasdaq: POAI), a pioneering company harnessing the power of artificial intelligence (AI) and machine learning (ML) to accelerate oncologic drug discovery, reported their financial and operational results for the quarter ended December 31, 2024. Financial Highlights…
Bronstein, Gewirtz & Grossman, LLC Files Class Action Lawsuit Against Ready Capital Corporation New York, NY – April 1, 2025 Bronstein, Gewirtz & Grossman, LLC, a leading national securities fraud law firm, announces that a class action lawsuit has been filed against Ready Capital Corporation (“Ready Capital” or “the Company”) (NYSE:RC) and certain of its…
Revolutionizing Migraine Management: Tonix Pharmaceuticals Introduces TONIX ONE™ In an era where digital health solutions are increasingly becoming the norm, Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a pioneering biopharmaceutical company, has taken a significant step forward in the migraine community. On April 1, 2025, Tonix Pharmaceuticals announced the launch of TONIX ONE™, a comprehensive digital…
The Euro’s Steady Performance Amidst Currency Fluctuations: A Closer Look The currency market saw a fascinating dance between the Euro (EUR) and the Pound (GBP) on Monday, with the Euro managing to maintain its ground despite a slight dip against the British currency. But what’s truly noteworthy is the Euro’s performance against several other currencies,…
